Amedeo Smart

Free Medical Literature Service


 

Amedeo

Fractures

  Free Subscription

Articles published in
Osteoporos Int
    July 2025
  1. BENNETT MJ, Center JR, Carter S, Moles R, et al
    Implementing pharmacist-led home medicines reviews within fracture liaison services for better post-fracture care: a qualitative study of patient and practitioner experience.
    Osteoporos Int. 2025 Jul 1. doi: 10.1007/s00198-025-07589.
    >> Share

  2. FERRARI S, Akesson KE, Al-Daghri N, Biver E, et al
    Bone microstructure and TBS in diabetes: what have we learned? A narrative review.
    Osteoporos Int. 2025;36:1115-1128.
    >> Share

    June 2025
  3. BARKER KL, Newman M, Knight R, Hannink E, et al
    Exercise rehabilitation with tailored support for exercise adherence for people with vertebral fragility fractures is more effective than standard rehabilitation: the OPTIN randomised controlled trial.
    Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07582.
    >> Share

  4. PARK J, Kim JW, Nam JH, Kim Y, et al
    Comparative analysis of osteoporotic versus pathologic fracture in metastatic colorectal cancer patients.
    Osteoporos Int. 2025 Jun 30. doi: 10.1007/s00198-025-07575.
    >> Share

  5. DEMERS AJ, Fitton LS, McCulley SML, Delgado-Arellanes I, et al
    Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up.
    Osteoporos Int. 2025 Jun 27. doi: 10.1007/s00198-025-07557.
    >> Share

  6. ZHAO AY, Chiu A, Agarwal AR, Harris AB, et al
    The growing burden of periprosthetic fractures after total hip arthroplasty: identifying overall trends and at-risk groups.
    Osteoporos Int. 2025 Jun 26. doi: 10.1007/s00198-025-07583.
    >> Share

  7. MCLAUGHLIN EC, Giangregorio LM, Adachi JD, Laing AC, et al
    Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.
    Osteoporos Int. 2025 Jun 25. doi: 10.1007/s00198-025-07435.
    >> Share

  8. WANG H, Zhao Y, Liu Q, Jiang Z, et al
    Global burden of low bone mineral density related fractures in pre- and post-menopausal women from 1990 to 2021, with projections to 2050.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07586.
    >> Share

  9. LIU M, Li Y
    Four-year trajectories of depressive symptoms and subsequent risk of hip fracture: evidence from China Health and Retirement Longitudinal Study.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07573.
    >> Share

  10. GADGAARD NR, Varnum C, Nelissen R, Vandenbroucke-Grauls C, et al
    Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010-2021.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07576.
    >> Share

  11. KAMIYA K, Kojima A, Tachiki T, Imai N, et al
    Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study.
    Osteoporos Int. 2025 Jun 23. doi: 10.1007/s00198-025-07577.
    >> Share

  12. TIMON C, Kotze N, Gantley K, Cassar-Gheiti AJ, et al
    Benefits of an advanced nurse practitioner led hip fracture clinic in an Irish Orthopaedic Trauma Service.
    Osteoporos Int. 2025 Jun 18. doi: 10.1007/s00198-025-07554.
    >> Share

  13. DING Q, Zhou B, Leung J, Kwok T, et al
    Global trends in burden of fractures, low bone mineral density, and high body mass index from 1990 to 2021, an age-period-cohort analysis.
    Osteoporos Int. 2025 Jun 17. doi: 10.1007/s00198-025-07570.
    >> Share

  14. MITSUTAKE S, Lystad RP, Okuba T, Long JC, et al
    Effect of hospital-acquired complications on hospital length of stay and cost for older adults after a hip fracture in New South Wales, Australia.
    Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07536.
    >> Share

  15. CUNNINGHAM C, Linehan P, Kilkenny F, Duffy J, et al
    Patient education following vertebral fragility fracture: a scoping review.
    Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07545.
    >> Share

  16. CARTER C, Guerra S, Clothier L, Barlow S, et al
    Rehabilitation after pelvic fragility fracture in older adults: a scoping review.
    Osteoporos Int. 2025 Jun 16. doi: 10.1007/s00198-025-07552.
    >> Share

  17. MARSELOU E, Kelekis A, Dimitriadis Z, Koumantakis GA, et al
    Risk factors for refracture or new vertebral compression fractures after percutaneous vertebroplasty: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07523.
    >> Share

  18. SHOGRY FF, Hayes KN, Kim S, Burden AM, et al
    The rise and fall of raloxifene use for osteoporosis, 1999-2022.
    Osteoporos Int. 2025 Jun 11. doi: 10.1007/s00198-025-07544.
    >> Share

  19. CHOI YH, Wong PY, Fong MK, Chau WW, et al
    A potential novel predictor of 1-year mortality in elderly hip fracture patients-albumin haemoglobin index.
    Osteoporos Int. 2025 Jun 10. doi: 10.1007/s00198-025-07566.
    >> Share

  20. HUANG CF, Ho CJ, Lin SY, Hwang JS, et al
    Asia-Pacific consensus for the management of osteoporosis in men.
    Osteoporos Int. 2025 Jun 4. doi: 10.1007/s00198-025-07559.
    >> Share

  21. CHAKHTOURA M, Akl E, Arabi A, Ahmadieh H, et al
    The Lebanese GRADE-based vitamin D guidelines: a paradigm for the MENA region.
    Osteoporos Int. 2025;36:937-950.
    >> Share

    May 2025
  22. RIPPL M, Grupp P, Martini S, Muller K, et al
    Characteristics and treatment options of 272,152 geriatric patients with very high and high fracture risk.
    Osteoporos Int. 2025 May 30. doi: 10.1007/s00198-025-07540.
    >> Share

  23. MASHARAWI Y, Lerner A, Weisman A
    Transcultural adaptation and validation of the QUALEFFO-41 Questionnaire for Hebrew-Speaking Israeli women with postmenopausal osteoporosis with and without vertebral fractures.
    Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07526.
    >> Share

  24. CHENG R, Zhang L
    Case report on possible causes of severe osteoporosis: diffuse panbronchiolitis.
    Osteoporos Int. 2025 May 28. doi: 10.1007/s00198-025-07532.
    >> Share

  25. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
    Author response to: among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2025 May 23. doi: 10.1007/s00198-025-07520.
    >> Share

  26. TAVANO FT, Silva ARB, Castro CHM, de Medeiros Pinheiro M, et al
    Secular trend of humeral fractures incidence rates in patients >/= 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013.
    Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07528.
    >> Share

  27. MONEGAL A, Carrasco JL, Peris P, Frade-Sosa B, et al
    Results of the implementation of a multidisciplinary care protocol for preventing fragility fractures following liver transplantation.
    Osteoporos Int. 2025 May 22. doi: 10.1007/s00198-025-07525.
    >> Share

  28. LOGGERS SAI, Geraerds AJLM, Joosse P, Willems HC, et al
    Correction to: Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study.
    Osteoporos Int. 2025 May 19. doi: 10.1007/s00198-025-07490.
    >> Share

  29. UM YJ, Cho IY, Koo HY, Park YM, et al
    Intellectual disabilities and risk of fractures: A population-based cohort study.
    Osteoporos Int. 2025 May 13. doi: 10.1007/s00198-025-07519.
    >> Share

  30. PRAVEEN AD, Jha D, Baker A, Fleps I, et al
    Comparison of the time-dependent discriminatory accuracy of femoral strength and bone mineral density for predicting future hip and major osteoporotic fractures: a 16-year follow-up of the AGES-Reykjavik cohort.
    Osteoporos Int. 2025 May 12. doi: 10.1007/s00198-025-07503.
    >> Share

  31. GUO L, Tian F
    Author response to: OSIN-D-25-00317, "Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population".
    Osteoporos Int. 2025 May 8. doi: 10.1007/s00198-025-07510.
    >> Share

  32. LIU E, Liu RY, Moraros J, McCloskey EV, et al
    Association between walking and hip fracture in women aged 65 and older: 20-year follow-up from the study of osteoporotic fractures.
    Osteoporos Int. 2025 May 7. doi: 10.1007/s00198-025-07508.
    >> Share

  33. WU Q, Jung J
    Precision fracture risk assessment: leveraging genomic and clinical data for personalized care.
    Osteoporos Int. 2025 May 6. doi: 10.1007/s00198-025-07517.
    >> Share

  34. WANG H, Huang Y
    Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population.
    Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07509.
    >> Share

  35. OUYANG W, Guo G, Zhao C
    Comment on: The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
    Osteoporos Int. 2025 May 2. doi: 10.1007/s00198-025-07430.
    >> Share

    April 2025
  36. HOUEL V, Marchasson G, Ramdane N, Philippoteaux C, et al
    Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis.
    Osteoporos Int. 2025 Apr 29. doi: 10.1007/s00198-025-07486.
    >> Share

  37. QI W, Cui L, Yin X, Yu W, et al
    Association between obesity and the prevalence of fractures: a population-based cross-sectional study in China.
    Osteoporos Int. 2025 Apr 28. doi: 10.1007/s00198-025-07493.
    >> Share

  38. ALBRECHT AP, Kistler-Fischbacher M, De Godoi Rezende Costa Molino C, Armbrecht G, et al
    Prevalence and incidence of osteoporotic vertebral fractures in community-dwelling European older adults: an observational analysis of the DO-HEALTH trial.
    Osteoporos Int. 2025 Apr 25. doi: 10.1007/s00198-025-07489.
    >> Share

  39. ADAMS H, Salman L, Drinkwater KJ, Griffin J, et al
    Improved radiological diagnosis of osteoporotic vertebral fragility fractures following UK-wide interventions and re-audit-can this be maintained and translated into clinical practice?
    Osteoporos Int. 2025 Apr 22. doi: 10.1007/s00198-025-07488.
    >> Share

  40. CHEN W, March LM, Blyth FM, Alarkawi D, et al
    Excess subsequent fracture and mortality risk after ankle fractures: a relative survival analysis of the 45 and Up Study.
    Osteoporos Int. 2025 Apr 10. doi: 10.1007/s00198-025-07400.
    >> Share

  41. RUGGIERO C, Baroni M, Pizzonia M, Giusti A, et al
    Pre-fracture functional status and 30-day recovery predict 5-year survival in patients with hip fracture: findings from a prospective real-world study.
    Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07427.
    >> Share

  42. ORHADJE E, Makaram N, Berg K, Hauser B, et al
    Clinical presentation, risk factors and management of pregnancy-associated osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Apr 9. doi: 10.1007/s00198-025-07479.
    >> Share

  43. BAUMANN AN, Krez AN, Trager RJ, Anaspure OS, et al
    Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study.
    Osteoporos Int. 2025 Apr 4. doi: 10.1007/s00198-025-07473.
    >> Share

  44. LIU L, Wang Y, Tan B, Huang P, et al
    Association of beta-adrenergic receptor blockers use with the risk of fracture in adults: a systematic review and meta-analysis.
    Osteoporos Int. 2025 Apr 2. doi: 10.1007/s00198-025-07471.
    >> Share

  45. GATINEAU G, Hind K, Shevroja E, Gonzalez-Rodriguez E, et al
    Advancing trabecular bone score (TBS): clinical performance of TBS version 4.0 with direct correction for soft tissue thickness-the osteolaus study.
    Osteoporos Int. 2025;36:715-724.
    >> Share

  46. KHAN AA, AbuAlrob H, Ali DS, Al Kassem Z, et al
    Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR).
    Osteoporos Int. 2025;36:673-684.
    >> Share

    March 2025
  47. BHATTOA HP, Vasikaran S, Trifonidi I, Kapoula G, et al
    Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Internatio
    Osteoporos Int. 2025 Mar 28. doi: 10.1007/s00198-025-07422.
    >> Share

  48. PAN Y, Wan Y, Wang Y, Yu T, et al
    Conventional chest computed tomography-based radiomics for predicting the risk of thoracolumbar osteoporotic vertebral fractures.
    Osteoporos Int. 2025 Mar 27. doi: 10.1007/s00198-024-07338.
    >> Share

  49. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
    Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
    Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07452.
    >> Share

  50. DOUNGSONG K, Davies J, Ezeofor V, Spencer LH, et al
    A cost-consequence analysis of a community-based rehabilitation programme following hip fracture (Fracture in the Elderly Multidisciplinary Rehabilitation-FEMuR III).
    Osteoporos Int. 2025 Mar 26. doi: 10.1007/s00198-025-07459.
    >> Share

  51. GERDHEM P, Wihlborg A, Bergstrom IB
    Site-specific volumetric skeletal changes in women with and without a distal forearm fracture: a case-control study with a mean 7-year follow-up.
    Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07412.
    >> Share

  52. CAPPOLA AR, Abraham DS, Kroopnick JM, Huang Y, et al
    Sex-specific associations of vitamin D and bone biomarkers with bone density and physical function during recovery from hip fracture: the Baltimore Hip Studies.
    Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07446.
    >> Share

  53. SOPINA L, Hitz MF, Thygesen LC, Langdahl B, et al
    Healthcare and productivity cost of osteoporosis: a Danish register-based quasi-experimental study.
    Osteoporos Int. 2025 Mar 20. doi: 10.1007/s00198-025-07453.
    >> Share

  54. PARK JH, Kwon O, Choi JH, Yeom JS, et al
    Perioperative teriparatide for preventing proximal junctional kyphosis and failure in patients with osteoporosis after adult thoracolumbar spinal deformity surgery: a prospective randomized controlled trial.
    Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07449.
    >> Share

  55. STARUP-LINDE J, Stoy J, Grinderslev PB, Langdahl B, et al
    Prevalence and risk factors for osteoporosis in type 1 diabetes-results from an observational study.
    Osteoporos Int. 2025 Mar 18. doi: 10.1007/s00198-025-07443.
    >> Share

  56. WU Q, Jung J
    Ensemble-learning approach improves fracture prediction using genomic and phenotypic data.
    Osteoporos Int. 2025 Mar 7. doi: 10.1007/s00198-025-07437.
    >> Share

  57. PARK JW, Kim HY, Kim KM, Kim J, et al
    Epidemiology of osteoporotic ankle fractures in South Korea: a nationwide retrospective cohort study (2006-2022).
    Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07429.
    >> Share

  58. BEAUDART C, Veronese N, Douxfils J, Thiyagarajan JA, et al
    PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis.
    Osteoporos Int. 2025 Mar 6. doi: 10.1007/s00198-025-07440.
    >> Share

  59. MCCARROLL K, Mahon J, Lannon R, Carroll A, et al
    Early administration of zoledronic acid after hip fracture.
    Osteoporos Int. 2025 Mar 5. doi: 10.1007/s00198-025-07450.
    >> Share

  60. LAURSEN N, Solling AS, Harslof T, Langdahl B, et al
    Clinical experience with denosumab discontinuation.
    Osteoporos Int. 2025;36:435-446.
    >> Share

    February 2025
  61. LIU J, Zhang Y, Yu W, Sun L, et al
    TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.
    Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07423.
    >> Share

  62. PETERSEN TG, Rubin KH, Javaid MK, Hermann AP, et al
    Long-term adherence to anti-osteoporosis medication and determinants of adherence in the population-based screening trial ROSE.
    Osteoporos Int. 2025 Feb 24. doi: 10.1007/s00198-025-07436.
    >> Share

  63. GUO L, Zhang N, Fan X, Hou X, et al
    The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population.
    Osteoporos Int. 2025 Feb 21. doi: 10.1007/s00198-025-07428.
    >> Share

  64. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.
    Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-025-07397.
    >> Share

  65. PAN S, Yang K, Wang K
    Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
    Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-024-07329.
    >> Share

  66. VAN OOSTWAARD MM, van den Bergh JP, Wyers CE
    Author response to the letter to the editor "Comment on: The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy" (OSIN-D-24-01632).
    Osteoporos Int. 2025 Feb 16. doi: 10.1007/s00198-024-07331.
    >> Share

  67. MAKKAR B, Obremskey W, Avidano R, Ott S, et al
    The definition of atypical femoral fractures should include periprosthetic femoral fractures (PAFFs).
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07401.
    >> Share

  68. NISSINEN T, Sund R, Suoranta S, Kroger H, et al
    Identifying proximal humerus fractures: an algorithmic approach using registers and radiological visit data.
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-025-07414.
    >> Share

  69. LO JC, Chandra M, Khan MM, Barzilay J, et al
    Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system.
    Osteoporos Int. 2025 Feb 7. doi: 10.1007/s00198-024-07372.
    >> Share

  70. NAKAJIMA K, Horii C, Kodama H, Shirokoshi T, et al
    Association between vertebral fractures and brain volume: insights from a community cohort study.
    Osteoporos Int. 2025 Feb 5. doi: 10.1007/s00198-025-07403.
    >> Share

    January 2025
  71. KAWAMURA K, Murata S, Kitano Y, Mera Y, et al
    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment.
    Osteoporos Int. 2025 Jan 28. doi: 10.1007/s00198-025-07404.
    >> Share

  72. DURBIN JW, Zhao AY, Cui E, Agarwal AR, et al
    Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020.
    Osteoporos Int. 2025 Jan 15. doi: 10.1007/s00198-025-07385.
    >> Share

  73. ANDREASEN C, Dahl C, Frihagen F, Borgen TT, et al
    Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative).
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-024-07376.
    >> Share

  74. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 14. doi: 10.1007/s00198-025-07383.
    >> Share

  75. CAO D, Cao Z, Liu A
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07374.
    >> Share

  76. HOLLTRO HT, Nilsen TIL, Schei B, Tronstad I, et al
    Is there an association between birth characteristics and fractures in young adults? The HUNT Study, Norway.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07361.
    >> Share

  77. AKKAN H, Seyyar GK
    Improving readability in AI-generated medical information on fragility fractures: the role of prompt wording on ChatGPT's responses.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07358.
    >> Share

  78. HUANG Z, Liao TC, Chuang AT, Shao SC, et al
    Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2025 Jan 8. doi: 10.1007/s00198-024-07381.
    >> Share

  79. HIRSCH JA, Gilligan C, Chandra RV, Brook A, et al
    Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study.
    Osteoporos Int. 2025;36:129-140.
    >> Share

    December 2024
  80. RAMSCHUTZ C, Sollmann N, El Husseini M, Kupfer K, et al
    Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults.
    Osteoporos Int. 2024 Dec 31. doi: 10.1007/s00198-024-07373.
    >> Share

  81. LIN YC, Chiang PH, Huang JY, Wu WS, et al
    Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07356.
    >> Share

  82. NAGENDRA L, Chandran M, Reginster JY, Bhadada SK, et al
    Cost-effectiveness of FRAX(R)-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis.
    Osteoporos Int. 2024 Dec 27. doi: 10.1007/s00198-024-07328.
    >> Share

  83. BLAKE RJ, Melemai VK, Fitzpatrick BM, Hubbard DF, et al
    Bilateral femoral neck fractures in pregnancy suggestive of transient osteoporosis of the hip in a patient with hyperparathyroidism: a case report.
    Osteoporos Int. 2024 Dec 24. doi: 10.1007/s00198-024-07346.
    >> Share

  84. YOEL U, Alkobi Weiss H, Goldbart A, Silverman Siris E, et al
    The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates-a single-center retrospective study.
    Osteoporos Int. 2024 Dec 18. doi: 10.1007/s00198-024-07325.
    >> Share

  85. CAO D, Chen J, Yu W
    Comment on: Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Dec 17. doi: 10.1007/s00198-024-07306.
    >> Share

  86. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Zahra Ali Haque, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07332.
    >> Share

  87. VAN OOSTWAARD M, van den Bergh JP, Wyers CE
    Author response to 01530, Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07322.
    >> Share

  88. RAZA MH, Bhutta ME, Siddique MH
    Proactive strategies for fracture risk in androgen deprivation therapy: a call for multidisciplinary collaboration.
    Osteoporos Int. 2024 Dec 16. doi: 10.1007/s00198-024-07330.
    >> Share

  89. KIM CH, Kim K, Kim JW
    The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07314.
    >> Share

  90. GONDO G, Shin JH, Kunisawa S, Imanaka Y, et al
    Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07269.
    >> Share

  91. NARLA RR, Adler RA
    Rationale for osteoporosis screening in men.
    Osteoporos Int. 2024 Dec 13. doi: 10.1007/s00198-024-07337.
    >> Share

  92. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Author Response to: Comment from Cheng Gu and Yu Cui on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07333.
    >> Share

  93. GU C, Cui Y
    Comment on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Dec 10. doi: 10.1007/s00198-024-07327.
    >> Share

  94. XU P, Luo J
    Comment on "Higher prevalence of thyroid?specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010".
    Osteoporos Int. 2024 Dec 9. doi: 10.1007/s00198-024-07334.
    >> Share

  95. SALMORAL A, Peris P, Lopez Medina C, Florez H, et al
    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.
    Osteoporos Int. 2024 Dec 3. doi: 10.1007/s00198-024-07309.
    >> Share

  96. MARTIN DP 2ND, Lake S, Behun M, Krueger D, et al
    Intraoperative physician assessment during total hip arthroplasty correlates with DXA parameters.
    Osteoporos Int. 2024;35:2145-2151.
    >> Share

  97. TSAI JN, Jordan M, Lee H, Leder BZ, et al
    One versus 2 years of alendronate following denosumab: the CARD extension.
    Osteoporos Int. 2024;35:2225-2230.
    >> Share

    November 2024
  98. AZAD TD, Wu RJ, Anderson KE, Darden M, et al
    Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage.
    Osteoporos Int. 2024 Nov 21. doi: 10.1007/s00198-024-07318.
    >> Share

  99. ONTAN MS, Cam Mahser A, Dost FS, Isik AT, et al
    Osteoporosis in older patients with idiopathic normal pressure hydrocephalus.
    Osteoporos Int. 2024 Nov 18. doi: 10.1007/s00198-024-07317.
    >> Share

  100. TAYLOR-WILLIAMS O, Keen H, Preen DB, Nossent J, et al
    First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities.
    Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07311.
    >> Share

  101. DE BRUIN IJA, Wyers CE, Vranken L, Schousboe JT, et al
    Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service.
    Osteoporos Int. 2024 Nov 12. doi: 10.1007/s00198-024-07288.
    >> Share

  102. SOOPRAMANIEN J, Wakefield A, Marshall L, Nightingale J, et al
    Assessing the impact of the 5 Nations Consensus Paper on IV Zolendronate administration post-hip fracture in older patients: experience from a UK teaching hospital.
    Osteoporos Int. 2024 Nov 4. doi: 10.1007/s00198-024-07303.
    >> Share

    October 2024
  103. CAO D, Gu N, Liu A
    Comment on: Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Oct 23. doi: 10.1007/s00198-024-07248.
    >> Share

  104. ZHOU K, Li R, Wang J
    Letter to the editor concerning "Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis".
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07287.
    >> Share

  105. IKI M, Fujimori K, Okimoto N, Nakatoh S, et al
    Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07284.
    >> Share

  106. SHARMA M, Beaudart C, Clark P, Fujiwara S, et al
    Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project.
    Osteoporos Int. 2024 Oct 21. doi: 10.1007/s00198-024-07264.
    >> Share

  107. TORO LA, Gonzalez FI, Botero S, Garcia HD, et al
    Handgrip strength as a predictor of 1?year mortality after hip fracture surgery in the Colombian Andes Mountains.
    Osteoporos Int. 2024 Oct 17. doi: 10.1007/s00198-024-07258.
    >> Share

  108. BARCELOS A, Lopes DG, Mazeda C, Canhao H, et al
    Regular physical activity improves physical function and health-related quality of life among middle-aged and older women who suffered a fragility fracture-a population-based cohort.
    Osteoporos Int. 2024 Oct 11. doi: 10.1007/s00198-024-07265.
    >> Share

  109. SAHOTA A, Vass C, Marshall L, Sahota O, et al
    Fragility fracture and fear of falling in middle aged adults-a prevalence study.
    Osteoporos Int. 2024 Oct 10. doi: 10.1007/s00198-024-07166.
    >> Share

  110. BORGSTROM F, Lorentzon M, Johansson H, Harvey NC, et al
    Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
    Osteoporos Int. 2024 Oct 4. doi: 10.1007/s00198-024-07251.
    >> Share

  111. SEO DH, Corr M, Patel S, Lui LY, et al
    Chemokine CXCL9, a marker of inflammaging, is associated with changes of muscle strength and mortality in older men.
    Osteoporos Int. 2024;35:1789-1796.
    >> Share

  112. SHARIFF JRR, Swe KM, Binkley N, Whyte MP, et al
    Skeletal fluorosis: an uncommon cause, yet a rescue treatment?
    Osteoporos Int. 2024;35:1859-1863.
    >> Share

    September 2024
  113. TAKEUCHI Y, Tanaka S, Kuroda T, Hagino H, et al
    Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2024 Sep 30. doi: 10.1007/s00198-024-07260.
    >> Share

  114. GIANGREGORIO LM, Alexiuk MR, Tangri N, Bohm C, et al
    Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07240.
    >> Share

  115. MASUDA S, Fukasawa T, Matsuda S, Yoshida S, et al
    Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.
    Osteoporos Int. 2024 Sep 25. doi: 10.1007/s00198-024-07255.
    >> Share

  116. VAN OOSTWAARD MM, Wyers CE, Driessen JHM, van Maren M, et al
    The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy.
    Osteoporos Int. 2024 Sep 18. doi: 10.1007/s00198-024-07180.
    >> Share

  117. GHASEMINEJAD-RAEINI A, Azarboo A, Zareshahi N, Jalali S, et al
    Early-life famine exposure and risk of osteoporosis and low bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Sep 13. doi: 10.1007/s00198-024-07250.
    >> Share

  118. ARMUTCU F, McCloskey E
    Insulin resistance, bone health, and fracture risk.
    Osteoporos Int. 2024 Sep 12. doi: 10.1007/s00198-024-07227.
    >> Share

  119. JAIN RK
    Comment on article "Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force Report on Clinical Algorithms for Fracture Risk".
    Osteoporos Int. 2024 Sep 4. doi: 10.1007/s00198-024-07242.
    >> Share

  120. KHAN AN, Jones RB Jr, Khan N, Yang YX, et al
    Trends in hip fracture rates in US male veterans.
    Osteoporos Int. 2024 Sep 3. doi: 10.1007/s00198-024-07236.
    >> Share

  121. LUO Y, Zheng S, Jiang S, Yang G, et al
    B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Osteoporos Int. 2024;35:1645-1659.
    >> Share

  122. MAHMUD M, Muscatello DJ, Rahman MB, Osborne NJ, et al
    Association between socioeconomic deprivation and bone health status in the UK biobank cohort participants.
    Osteoporos Int. 2024;35:1573-1584.
    >> Share

    August 2024
  123. LIN CJ, Liu SJ, Lin KY
    Author response to OSIN-D-24-00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07201.
    >> Share

  124. LI J, Zheng J
    Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Aug 29. doi: 10.1007/s00198-024-07200.
    >> Share

  125. FAN Z, Zhao J, Chen J, Hu W, et al
    Causal associations of osteoporosis with stroke: a bidirectional Mendelian randomization study.
    Osteoporos Int. 2024 Aug 24. doi: 10.1007/s00198-024-07235.
    >> Share

  126. MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
    Correction: Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
    Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07226.
    >> Share

  127. ZHOU Q, Chen J
    Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social.
    Osteoporos Int. 2024 Aug 16. doi: 10.1007/s00198-024-07186.
    >> Share

  128. JAIN RK, Polley E, Weiner M, Iwamaye A, et al
    An electronic health record (EHR)-based risk calculator can predict fractures comparably to FRAX: a proof-of-concept study.
    Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07221.
    >> Share

  129. TRAN TS, Bliuc D, Blank RD, Center JR, et al
    Fracture risk assessment in the presence of competing risk of death.
    Osteoporos Int. 2024 Aug 15. doi: 10.1007/s00198-024-07224.
    >> Share

  130. MCCARROLL K, Fitzpatrick D, Lannon R
    Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07218.
    >> Share

  131. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    Author response to: OSIN-D-24-00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Aug 9. doi: 10.1007/s00198-024-07214.
    >> Share

  132. ZENG Y, Yang Y, Wang J, Meng G, et al
    The Healing and therapeutic effects of perioperative bisphosphonate use in patients with fragility fractures: meta-analysis of 19 clinical trials.
    Osteoporos Int. 2024 Aug 8. doi: 10.1007/s00198-024-07191.
    >> Share

  133. GANDHAM A, Gregori G, Johansson L, Larsson BAM, et al
    Sarcopenia definitions and their association with injurious falls in older Swedish women from the Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone fractures (SUPERB) study.
    Osteoporos Int. 2024 Aug 6. doi: 10.1007/s00198-024-07196.
    >> Share

  134. HADJI P, Kamali L, Thomasius F, Horas K, et al
    Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER((R)) and high-resolution peripheral co
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07208.
    >> Share

  135. KIRK JM, Rathbun AM, Gruber-Baldini AL, Hochberg MC, et al
    Sex differences and predictors of anti-osteoporosis medication use in the 12 months after hip fracture surgery in adults 65 or older.
    Osteoporos Int. 2024 Aug 2. doi: 10.1007/s00198-024-07211.
    >> Share

    July 2024
  136. MITSUTAKE S, Lystad RP, Long JC, Braithwaite J, et al
    Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture.
    Osteoporos Int. 2024 Jul 31. doi: 10.1007/s00198-024-07203.
    >> Share

  137. TAYLOR L, Matsunaga M, Ahn HJ, Siu AM, et al
    Risk factors associated with 1-year mortality after osteoporotic hip fracture in Hawai'i: higher mortality risk among Native Hawaiians and other Pacific Islanders.
    Osteoporos Int. 2024 Jul 30. doi: 10.1007/s00198-024-07195.
    >> Share

  138. MAZEDA C, Azevedo SF, Barcelos A
    What the American Society of Anesthesiologists classification scores tell us after a hip fracture?
    Osteoporos Int. 2024 Jul 26. doi: 10.1007/s00198-024-07199.
    >> Share

  139. LE HV, Van BW, Shahzad H, Teng P, et al
    Fracture liaison service-a multidisciplinary approach to osteoporosis management.
    Osteoporos Int. 2024 Jul 18. doi: 10.1007/s00198-024-07181.
    >> Share

  140. SCHWARCZ Y, Yanover C, Rouach V, Luria S, et al
    Non-osteoporotic fractures are associated with increased risk of subsequent major osteoporotic fractures.
    Osteoporos Int. 2024 Jul 13. doi: 10.1007/s00198-024-07169.
    >> Share

  141. JOHANSSON P, Kristjansdottir HL, Johansson H, Mellstrom D, et al
    Increased risk of hip and major osteoporotic fractures in 8463 patients who have undergone stem cell transplantation, a Swedish population-based study.
    Osteoporos Int. 2024 Jul 8. doi: 10.1007/s00198-024-07171.
    >> Share

  142. MOBERG L, Jehpsson L, Nilsson PM, Rosengren B, et al
    Birth weight and birth length affect future fracture risk differently in men and women.
    Osteoporos Int. 2024 Jul 5. doi: 10.1007/s00198-024-07172.
    >> Share

  143. HEUSER L, Schoeneberg C, Rascher K, Lendemans S, et al
    Validation of the Geriatrics at Risk Score (GeRi-Score) on 120-day follow-up, the influence of preoperative geriatric visits, and the time to surgery on the outcome of hip fracture patients: an analysis from the Registry for Geriatric Trauma (ATR-DGU)
    Osteoporos Int. 2024 Jul 4. doi: 10.1007/s00198-024-07177.
    >> Share

  144. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.
    Osteoporos Int. 2024 Jul 3. doi: 10.1007/s00198-024-07162.
    >> Share

  145. BENSKY MJ, Adler L, Banon T, Gabay L, et al
    Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07174.
    >> Share

  146. PARK SY, Ahn SH, Bae GH, Jang S, et al
    Low-dose glucocorticoid increase the risk of fracture in postmenopausal women with low bone mass: a retrospective cohort study.
    Osteoporos Int. 2024 Jul 2. doi: 10.1007/s00198-024-07159.
    >> Share

  147. KIMURA S, Sunouchi T, Watanabe S, Hoshino Y, et al
    Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.
    Osteoporos Int. 2024 Jul 1. doi: 10.1007/s00198-024-07168.
    >> Share

    June 2024
  148. HESTNES I, Solberg LB, Meyer HE, Sundet M, et al
    The hip fracture incidence in the high-risk area Oslo continues to decline.
    Osteoporos Int. 2024 Jun 26. doi: 10.1007/s00198-024-07156.
    >> Share

  149. HOLVIK K, Dahl C, Samuelsen SO, Sogaard AJ, et al
    Educational gradient in hip fracture incidence in Norway. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2024 Jun 25. doi: 10.1007/s00198-024-07133.
    >> Share

  150. BARZILAY JI, Buzkova P, Bielinski SJ, Cotch MF, et al
    The association of microvascular disease and endothelial dysfunction with vertebral trabecular bone mineral density : The MESA study.
    Osteoporos Int. 2024 Jun 24. doi: 10.1007/s00198-024-07152.
    >> Share

  151. MUZZAMMIL M, Bhura S, Hussain AS, Bashir S, et al
    Undiagnosed vertebral fragility fractures in patients with distal radius fragility fractures: an opportunity for prevention of morbimortality in osteoporotic patients in developing countries.
    Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07149.
    >> Share

  152. ZHAO AY, Ferraro S, Agarwal A, Mikula JD, et al
    Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty.
    Osteoporos Int. 2024 Jun 20. doi: 10.1007/s00198-024-07147.
    >> Share

  153. SO E, Juels C, Scott RT, Sietsema DL, et al
    A comparison of foot fractures relative to other fragility fractures: a review and analysis of the American Orthopaedic Association's Own the Bone Database.
    Osteoporos Int. 2024 Jun 18. doi: 10.1007/s00198-024-07153.
    >> Share

  154. MILTON-COLE R, Sheehan KJ
    Author response to: OSIN-D-24-00452, "Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis".
    Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07125.
    >> Share

  155. WU H, Xiao H
    Comment on: Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Jun 14. doi: 10.1007/s00198-024-07124.
    >> Share

  156. XU MZ, Lu K, Ye YW, Xu SM, et al
    Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis.
    Osteoporos Int. 2024 Jun 6. doi: 10.1007/s00198-024-07142.
    >> Share

  157. GKANIATSA E, Sandstrom TZ, Rosengren A, Trimpou P, et al
    Hip fractures in patients with primary aldosteronism - a Swedish nationwide study.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07132.
    >> Share

  158. LAROSE G, Al-Azazi S, Lix LM, Bohm E, et al
    Introduction of an order set after hip fracture improves osteoporosis medication initiation and persistence: a population-based before-after analysis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07131.
    >> Share

  159. KUMAR S, Gild ML, McDonald MM, Kim AS, et al
    A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis.
    Osteoporos Int. 2024 Jun 5. doi: 10.1007/s00198-024-07139.
    >> Share

  160. CHARATCHAROENWITTHAYA N, Nimitphong H, Wattanachanya L, Songpatanasilp T, et al
    Epidemiology of hip fractures in Thailand.
    Osteoporos Int. 2024 Jun 4. doi: 10.1007/s00198-024-07140.
    >> Share

  161. TAHMASBI F, Sadoughi F, Sheikhtaheri A, Zabihiyeganeh M, et al
    Developing fracture liaison service framework based on comparative analysis and scoping review.
    Osteoporos Int. 2024 Jun 3. doi: 10.1007/s00198-024-07091.
    >> Share

  162. ZHOU L, Zhou H, Xu H, Sun X, et al
    Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
    Osteoporos Int. 2024;35:997-1005.
    >> Share

    May 2024
  163. CHANDRASOMA D, Chiu S, Niddrie F, Major G, et al
    Should major trauma fractures be part of a fracture liaison service's remit: a cost-benefit estimate.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07134.
    >> Share

  164. PARK YB, Kim M, Nam HC, Jeon JW, et al
    Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture.
    Osteoporos Int. 2024 May 27. doi: 10.1007/s00198-024-07138.
    >> Share

  165. MENNEN AHM, Maas M, van Embden D
    Letter of rebuttal to 'Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review'.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07117.
    >> Share

  166. ZHANG Y, Lu M, Wang L
    Comment on: imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
    Osteoporos Int. 2024 May 21. doi: 10.1007/s00198-024-07107.
    >> Share

  167. WANG X, Zhao X
    Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07098.
    >> Share

  168. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Author Response to OSIN-D-24-00437: Letter to the Editor regarding "Associations between ultra-distal forearm bone mineral density and incident fracture in women".
    Osteoporos Int. 2024 May 20. doi: 10.1007/s00198-024-07094.
    >> Share

  169. DAGNELIE PC, Willems PC, Jorgensen NR
    Nutritional status as independent prognostic factor of outcome and mortality until five years after hip fracture: a comprehensive prospective study.
    Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07088.
    >> Share

  170. ANSARI H, Jaglal S, Cheung AM, Jain R, et al
    Osteoporosis management in adults with schizophrenia following index hip fracture event: a 10-year population-based retrospective cohort study, Ontario, Canada.
    Osteoporos Int. 2024 May 17. doi: 10.1007/s00198-024-07123.
    >> Share

  171. TAKAKUBO Y, Miyaji T, Ota D, Takahashi T, et al
    Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07116.
    >> Share

  172. LIN CJ, Lee YS, Yeh JH, Liu SJ, et al
    The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 15. doi: 10.1007/s00198-024-07097.
    >> Share

  173. ALI A, Huszti E, Noordin S, Ali U, et al
    Examining treatment targets and equity in bone-active medication use within secondary fracture prevention: a systematic review and meta-analysis.
    Osteoporos Int. 2024 May 14. doi: 10.1007/s00198-024-07078.
    >> Share

  174. FUNAKOSHI Y, Maruyama K, Kato T, Saito I, et al
    Association of depressive symptoms with incident fractures: the Japan Public Health Center-based Prospective Study for the Next Generation (JPHC-NEXT).
    Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07106.
    >> Share

  175. KOBAYASHI T, Morimoto T, Ito K, Mawatari M, et al
    Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.
    Osteoporos Int. 2024 May 11. doi: 10.1007/s00198-024-07118.
    >> Share

  176. XIAO X, Wu Q
    Enhanced fracture risk prediction: a novel multi-trait genetic approach integrating polygenic scores of fracture-related traits.
    Osteoporos Int. 2024 May 7. doi: 10.1007/s00198-024-07105.
    >> Share

  177. LIU B, Ng CY, La PBD, Wong P, et al
    Osteoporosis and fracture risk assessment in adults with ischaemic stroke.
    Osteoporos Int. 2024 May 4. doi: 10.1007/s00198-024-07099.
    >> Share

    April 2024
  178. PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
    Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
    >> Share

  179. GOLD DT, Beckett T, Deal C, James AL, et al
    Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
    >> Share

  180. WANG M, Seibel MJ
    Secondary fracture prevention in primary care: a narrative review.
    Osteoporos Int. 2024 Apr 23. doi: 10.1007/s00198-024-07036.
    >> Share

  181. AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
    The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
    >> Share

  182. ZUBICK P, Dahlke S
    Family/caregiver influence on osteoporosis management for older people: an integrative review.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
    >> Share

  183. WU J, Li J, Yan Z, Yu X, et al
    Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: results from NHANES 2007-2010.
    Osteoporos Int. 2024 Apr 12. doi: 10.1007/s00198-024-07083.
    >> Share

  184. XIN Z, Xu H, Zhang X, Samelson EJ, et al
    Association of bone fracture with 30-year body mass index (BMI) trajectories: findings from the Framingham Heart Study : Bone fracture and 30-year BMI trajectories.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07068.
    >> Share

  185. CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
    >> Share

  186. LEMS WF, van den Bergh JP, Geusens P
    Follow-up in Fracture Liaisons Services: the involvement of general practitioners and fracture nurses is urgently needed.
    Osteoporos Int. 2024 Apr 6. doi: 10.1007/s00198-024-07079.
    >> Share

  187. LANE J, Langdahl B, Stone M, Kurth A, et al
    Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials.
    Osteoporos Int. 2024 Apr 4. doi: 10.1007/s00198-024-07049.
    >> Share

  188. GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
    >> Share

  189. ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
    The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
    >> Share

  190. WHITING PS, Hare K, Krueger D, Borchardt G, et al
    Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
    Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
    >> Share

    March 2024
  191. KOBAYASHI T, Morimoto T, Mawatari M
    Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
    Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
    >> Share

  192. DANAZUMI MS, Lightbody N, Dermody G
    Effectiveness of fracture liaison service in reducing the risk of secondary fragility fractures in adults aged 50 and older: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-024-07052.
    >> Share

  193. CAI Y, Jun G, Zhuang X
    Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
    >> Share

  194. LORENTZON M, Litsne H, Axelsson KF
    The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
    Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
    >> Share

  195. LI D, Mao SS, Budoff MJ
    Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
    Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
    >> Share

  196. PLUSKIEWICZ W, Tabor E
    The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
    >> Share

  197. MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
    The yield of routine laboratory examination in osteoporosis evaluation in primary care.
    Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
    >> Share

  198. TAGUCHI A
    Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
    Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
    >> Share

  199. CRANDALL CJ, Larson J, Shadyab AH, LeBoff MS, et al
    Physical function trajectory after wrist or lower arm fracture in postmenopausal women: results from the Women's Health Initiative Study.
    Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07050.
    >> Share

  200. CLARK P, Cruz-Priego GA, Rascon-Pacheco RA, Bremer A, et al
    Incidence of hip fractures in Mexico 2006-2019: increasing numbers but decreasing rates.
    Osteoporos Int. 2024 Mar 9. doi: 10.1007/s00198-024-07045.
    >> Share

  201. KAY RS, Ho L, Clement ND, Duckworth AD, et al
    The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07039.
    >> Share

  202. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Associations between ultra-distal forearm bone mineral density and incident fracture in women.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
    >> Share

    February 2024
  203. LIPPUNER K, Kyuchukova M, Schwab P, Rizzoli R, et al
    Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021-reversal of the secular trend?
    Osteoporos Int. 2024 Feb 24. doi: 10.1007/s00198-024-07016.
    >> Share

  204. PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
    CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
    >> Share

  205. SCHENE MR, Willems HC, Driessen JHM, Vranken L, et al
    Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service.
    Osteoporos Int. 2024 Feb 13. doi: 10.1007/s00198-023-07009.
    >> Share

  206. XU L, Zhao T, Perry L, Frost SA, et al
    Return on investment of fracture liaison services: a systematic review and analysis.
    Osteoporos Int. 2024 Feb 1. doi: 10.1007/s00198-024-07027.
    >> Share

  207. CHATTARIS T, Yang L, Johansson H, Sahni S, et al
    Performance of FRAX in older adults with frailty: the Framingham Heart Study.
    Osteoporos Int. 2024;35:265-275.
    >> Share

    January 2024
  208. YU W, Guan WM, Hayashi D, Lin Q, et al
    Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
    >> Share

  209. CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
    Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
    Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
    >> Share

  210. SMITH TO, Brown O, Baxter MA
    Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography.
    Osteoporos Int. 2024 Jan 27. doi: 10.1007/s00198-024-07030.
    >> Share

  211. SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
    Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
    >> Share

  212. BENNETT MJ, Center JR, Perry L
    Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
    >> Share

  213. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
    Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
    >> Share

  214. JEON S, Yu D, Kim S, Kim SW, et al
    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
    Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
    >> Share

  215. CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
    Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
    >> Share

  216. BYUN SE, Kim H, Lee SY, Kim SM, et al
    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
    Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
    >> Share

  217. SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
    Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
    >> Share

  218. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
    Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
    >> Share

  219. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
    Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
    >> Share

  220. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
    Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
    >> Share

  221. MULKERRIN P, O'Shea F, Fitzgerald G
    Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
    >> Share

  222. BHATTACHARYA S, Nagendra L, Chandran M, Kapoor N, et al
    Trabecular bone score in adults with type 1 diabetes: a meta-analysis.
    Osteoporos Int. 2024;35:105-115.
    >> Share

    December 2023
  223. YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
    Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
    Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
    >> Share

  224. YOO JE, Huh Y, Kim E, Park SH, et al
    Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
    Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
    >> Share

  225. ANDREASEN C, Dahl C, Solberg LB, Borgen TT, et al
    Epidemiology of forearm fractures in women and men in Norway 2008-2019.
    Osteoporos Int. 2023 Dec 12. doi: 10.1007/s00198-023-06990.
    >> Share

  226. ZHOU YF, Wang J, Wang XL, Song SS, et al
    A prediction model of elderly hip fracture mortality including preoperative red cell distribution width constructed based on the random survival forest (RSF) and Cox risk ratio regression.
    Osteoporos Int. 2023 Dec 7. doi: 10.1007/s00198-023-06988.
    >> Share

  227. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
    Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
    >> Share

    November 2023
  228. HOU XL, Liu JY, Fan XH, Zhang N, et al
    Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China.
    Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06987.
    >> Share

  229. PERIS P, Blasco J, Monegal A, Florez H, et al
    Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures.
    Osteoporos Int. 2023 Nov 30. doi: 10.1007/s00198-023-06960.
    >> Share

  230. BUI M, Nijmeijer WS, Hegeman JH, Witteveen A, et al
    Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery.
    Osteoporos Int. 2023 Nov 24. doi: 10.1007/s00198-023-06942.
    >> Share

  231. BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
    Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
    Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
    >> Share

  232. KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
    Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
    Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
    >> Share

  233. AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
    The incremental risk of fragility fractures in aging men.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
    >> Share

  234. JAVAID MK, Calo M, Wullich S, Mohsin Z, et al
    Development, implementation and evaluation of a multinational FLS mentorship programme in Latin America.
    Osteoporos Int. 2023;34:1881-1891.
    >> Share

    October 2023
  235. HALL AJ, Clement ND, MacLullich AMJ, White TO, et al
    Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study.
    Osteoporos Int. 2023 Oct 28. doi: 10.1007/s00198-023-06954.
    >> Share

  236. HAN S, Kim S, Yeh EJ, Suh HS, et al
    Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
    >> Share

  237. INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
    Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
    >> Share

  238. LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
    Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
    >> Share

  239. MITCHELL DM, Singhal V, Nimmala S, Lauze M, et al
    Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults.
    Osteoporos Int. 2023 Oct 21. doi: 10.1007/s00198-023-06941.
    >> Share

  240. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
    >> Share

  241. ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
    Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
    >> Share

  242. MILTON-COLE R, Kazeem K, Gibson A, Guerra S, et al
    Effectiveness of exercise rehabilitation interventions on depressive symptoms in older adults post hip fracture: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06923.
    >> Share

  243. PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
    Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
    >> Share

  244. REILAND K, Haastert B, Arend W, Kluppelholz B, et al
    Epidemiology of distal radius fractures in Germany - incidence rates and trends based on inpatient and outpatient data.
    Osteoporos Int. 2023 Oct 11. doi: 10.1007/s00198-023-06904.
    >> Share

  245. YAN F, Wu L, Lang J, Huang Z, et al
    Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
    >> Share

  246. TARALDSEN K, Polhemus A, Engdal M, Jansen CP, et al
    Evaluation of mobility recovery after hip fracture: a scoping review of randomized controlled studies.
    Osteoporos Int. 2023 Oct 6. doi: 10.1007/s00198-023-06922.
    >> Share

  247. LI N, van den Bergh JP, Boonen A, Wyers CE, et al
    Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
    Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
    >> Share

  248. OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
    Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
    Osteoporos Int. 2023;34:1799-1804.
    >> Share

    September 2023
  249. MAAS L, Raskin N, van Onna M, Cornelissen D, et al
    Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
    >> Share

  250. HUNG WC, Lin YL, Cheng TT, Chin WL, et al
    Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
    Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
    >> Share

  251. LIU X, Makaroff KE, Almario CV, Khalil C, et al
    Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
    >> Share

  252. ELWAKIL W, El Gaafary M, El Miedany Y
    Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
    >> Share

  253. FENG JN, Zhang CG, Li BH, Zhan SY, et al
    Global burden of hip fracture: The Global Burden of Disease Study.
    Osteoporos Int. 2023 Sep 14. doi: 10.1007/s00198-023-06907.
    >> Share

  254. CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
    Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
    >> Share

  255. LU K, Wu YM, Shi Q, Gong YQ, et al
    A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
    >> Share

  256. WANG X, Zhang F, Zhang Y, Zhang J, et al
    Effect of SGLT2 inhibitors on fractures, BMD, and bone metabolism markers in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Sep 11. doi: 10.1007/s00198-023-06908.
    >> Share

  257. NICOLAES J, Liu Y, Zhao Y, Huang P, et al
    External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
    Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
    >> Share

  258. RAUF MA, Kotecha J, Moss K
    Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology.
    Osteoporos Int. 2023;34:1647-1652.
    >> Share

    August 2023
  259. MOAYYERI A, Warden J, Han S, Suh HS, et al
    Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
    >> Share

  260. BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
    Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
    Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
    >> Share

  261. BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
    >> Share

  262. HONG N, Shin S, Lee S, Rhee Y, et al
    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
    >> Share

  263. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Aug 18. doi: 10.1007/s00198-023-06887.
    >> Share

  264. TURABI RY, Sheehan KJ
    Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
    >> Share

  265. MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
    The importance of structural barriers of osteoporotic hip fracture in the elderly.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
    >> Share

  266. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
    Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
    >> Share

  267. SKULADOTTIR SS, Hjaltadottir I, Launer L, Cotch MF, et al
    Milk intake and hip fracture incidence in community-dwelling old Icelandic adults.
    Osteoporos Int. 2023 Aug 10. doi: 10.1007/s00198-023-06883.
    >> Share

  268. SEO DH, Jeong Y, Cho Y, Kim SH, et al
    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
    >> Share

  269. DOUSSIERE M, Jesson C, Diep L, Menis J, et al
    Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06868.
    >> Share

  270. FITZPATRICK D, Lannon R, Laird E, Ward M, et al
    The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture-results of a large observational cohort study.
    Osteoporos Int. 2023 Aug 2. doi: 10.1007/s00198-023-06867.
    >> Share

  271. FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
    Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
    Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
    >> Share

  272. ZITTERMANN A, Schmidt A, Haardt J, Kalotai N, et al
    Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society.
    Osteoporos Int. 2023;34:1335-1353.
    >> Share

    July 2023
  273. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
    >> Share

  274. THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
    >> Share

  275. TSAI YL, Wu CH, Li CC, Shih CA, et al
    Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients.
    Osteoporos Int. 2023 Jul 19. doi: 10.1007/s00198-023-06845.
    >> Share

  276. SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
    Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
    >> Share

  277. JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
    The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
    >> Share

  278. SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
    Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
    >> Share

    June 2023
  279. SCHOUSBOE JT, Binkley N, Leslie WD
    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
    Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
    >> Share

  280. ZHANG X, Yang M, Zhang J, Ye P, et al
    Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry.
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06832.
    >> Share

  281. YEH EJ, Rajkovic-Hooley O, Silvey M, Ambler WS, et al
    Impact of fragility fractures on activities of daily living and productivity in community-dwelling women: a multi-national study.
    Osteoporos Int. 2023 Jun 19. doi: 10.1007/s00198-023-06822.
    >> Share

  282. GADGAARD NR, Varnum C, Nelissen RGHH, Vandenbroucke-Grauls C, et al
    Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study.
    Osteoporos Int. 2023 Jun 17. doi: 10.1007/s00198-023-06823.
    >> Share

  283. HAGINO H, Moriwaki K, Wada T, Osaki M, et al
    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
    >> Share

  284. HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
    Osteoporosis medication adherence tools: a systematic review.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
    >> Share

  285. MENNEN AHM, Blokland AS, Maas M, van Embden D, et al
    Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review.
    Osteoporos Int. 2023 Jun 7. doi: 10.1007/s00198-023-06812.
    >> Share

    May 2023
  286. LU K, Wu YM, Shi Q, Gong YQ, et al
    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
    >> Share

  287. CHATTARIS T, Chahal K, Berry SD
    Factors besides frailty index affect length of stay in older patients with hip fractures.
    Osteoporos Int. 2023 May 29:1-2. doi: 10.1007/s00198-023-06798.
    >> Share

  288. GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
    Mortality among older adults with osteoporotic vertebral fracture.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
    >> Share

  289. KWON H, Han KD, Kim BS, Moon SJ, et al
    Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
    >> Share

  290. KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
    >> Share

  291. YANG H, Bai J, Li L, Yang Y, et al
    Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
    >> Share

  292. KONG SH, Kim S, Kim Y, Kim JH, et al
    Development and validation of common data model-based fracture prediction model using machine learning algorithm.
    Osteoporos Int. 2023 May 17. doi: 10.1007/s00198-023-06787.
    >> Share

  293. AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
    The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
    Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
    >> Share

  294. AVGERINOU C, Petersen I, Clegg A, West RM, et al
    Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
    Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
    >> Share

  295. METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
    Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
    Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
    >> Share

    April 2023
  296. MYUNG SK, Cho H
    Effects of intermittent or single high-dose vitamin D supplementation on risk of falls and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06761.
    >> Share

  297. ZEELENBERG ML, Den Hartog D, Panneman MJM, Polinder S, et al
    Trends in incidence, health care consumption, and costs for proximal femoral fractures in the Netherlands between 2000 and 2019: a nationwide study.
    Osteoporos Int. 2023 Apr 29. doi: 10.1007/s00198-023-06774.
    >> Share

  298. RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
    Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
    >> Share

  299. LEE RH, Bain J, Muehlbauer M, Ilkayeva O, et al
    Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case-control study.
    Osteoporos Int. 2023 Apr 26. doi: 10.1007/s00198-023-06763.
    >> Share

  300. BYUN SE, Lee KJ, Shin WC, Moon NH, et al
    The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 25. doi: 10.1007/s00198-023-06768.
    >> Share

  301. SOLAIMAN RH, Irfanullah E, Navarro SM, Keil EJ, et al
    Rising incidence of stair-related upper extremity fractures among older adults in the United States: a 10-year nationwide analysis.
    Osteoporos Int. 2023 Apr 24:1-8. doi: 10.1007/s00198-023-06769.
    >> Share

  302. BENNETT MJ, Center JR, Perry L
    Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
    Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
    >> Share

  303. TSUTSUI T, Fujiwara T, Matsumoto Y, Kimura A, et al
    Geriatric nutritional risk index as the prognostic factor in older patients with fragility hip fractures.
    Osteoporos Int. 2023 Apr 17. doi: 10.1007/s00198-023-06753.
    >> Share

  304. PONZANO M, Tibert N, Brien S, Funnell L, et al
    Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
    >> Share

  305. YANG T, Wu J, Ding X, Zhou B, et al
    The association of melatonin use and hip fracture: a matched cohort study.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06740.
    >> Share

  306. ICONARU L, Charles A, Baleanu F, Moreau M, et al
    Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
    Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
    >> Share

  307. TURABI RY, Wyatt D, Guerra S, O'Connell MDL, et al
    Barriers and facilitators of weight bearing after hip fracture surgery among older adults. A scoping review.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-023-06735.
    >> Share

  308. KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
    Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
    >> Share

  309. TANG Y, Zhang L, Ye D, Zhao A, et al
    Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
    Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
    >> Share

    March 2023
  310. GOEL H, Binkley N, Hans D, Leslie WD, et al
    Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
    >> Share

  311. BAILLET M, Morello R, Vittecoq O, Chavoix C, et al
    Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study.
    Osteoporos Int. 2023 Mar 24. doi: 10.1007/s00198-023-06701.
    >> Share

  312. BINKLEY N, Nickel B, Anderson PA
    Periprosthetic fractures: an unrecognized osteoporosis crisis.
    Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
    >> Share

  313. BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
    Epidemiology of male osteoporosis in Denmark (1996-2018).
    Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
    >> Share

  314. SCHOENEBERG C, Heuser L, Rascher K, Lendemans S, et al
    The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture - a development and validation study from the Registry for Geriatric Trauma (ATR-DGU).
    Osteoporos Int. 2023 Mar 9. doi: 10.1007/s00198-023-06719.
    >> Share

  315. EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
    Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
    Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
    >> Share

  316. WALSH ME, Cunningham C, Brent L, Savin B, et al
    Long-term outcome collection after hip fracture in Ireland: a systematic review of traditional and grey literature.
    Osteoporos Int. 2023 Mar 4. doi: 10.1007/s00198-023-06713.
    >> Share

  317. TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
    Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
    >> Share

  318. HANS D, McDermott M, Huang S, Kim M, et al
    Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
    >> Share

  319. NIJMEIJER WS, Voorthuis BJ, Groothuis-Oudshoorn CGM, Wurdemann FS, et al
    The prediction of early mortality following hip fracture surgery in patients aged 90 years and older: the Almelo Hip Fracture Score 90 (AHFS(90)).
    Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06696.
    >> Share

    February 2023
  320. JUNG SY, Cho EB, Han KD, Jung JH, et al
    Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
    >> Share

  321. HE D, Pan C, Zhao Y, Wei W, et al
    Exome-wide screening identifies novel rare risk variants for bone mineral density.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
    >> Share

  322. XIAO X, Wu Q
    Ethnic disparities in fracture risk assessment using polygenic scores.
    Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
    >> Share

  323. ABDALBARY M, Chishti E, Shakhashiro M, Mohamed R, et al
    Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Osteoporos Int. 2023 Feb 15. doi: 10.1007/s00198-023-06686.
    >> Share

  324. ARMSTRONG P, Kuo YF, Cram P, Westra J, et al
    National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06680.
    >> Share

    January 2023
  325. VERDONCK C, Willems R, Borgermans L
    Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review.
    Osteoporos Int. 2023 Jan 25. doi: 10.1007/s00198-023-06678.
    >> Share

  326. KHAN MI
    Management of bone loss due to endocrine therapy during cancer treatment.
    Osteoporos Int. 2023 Jan 19. doi: 10.1007/s00198-023-06672.
    >> Share

    December 2022
  327. NEWSON L, Ball S, Lewis R
    Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines.
    Osteoporos Int. 2022 Dec 28. doi: 10.1007/s00198-022-06619.
    >> Share

  328. YU G, Tong S, Liu J, Wan Y, et al
    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis.
    Osteoporos Int. 2022 Dec 17. doi: 10.1007/s00198-022-06626.
    >> Share

    November 2022
  329. GAO SS, Zhao Y
    The effects of beta-carotene on osteoporosis: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06593.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016